The latest LifeSci SPAC said it is targeting companies in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors. Read more.
Related Posts
Swiftmerge Acquisition Files $250M IPO
The SPAC intends to target businesses in the "innovative consumer" space -- companies using technology and the Internet to evolve the way consumers interact with the marketplace.
North Atlantic Acquisition Amends Prospectus on $300M IPO
The new SPAC is focused on targets that operate in Europe in the consumer, industrials and telecommunications sectors.
Jiya Amends $100M IPO Prospectus
The SPAC is focused on biopharmaceutical companies.
American Acquisition Opportunity Prices $100M IPO
The SPAC intends to focus its search on land and resource holding companies, with the potential to create, support, and/or innovate for the new economy.